Fiedler, Walter, Pau Montesinos, Christoph Schliemann, Jan Middeke, Sumithira Vasu, Christian W. Scholz, Jordi Esteve, Shoubhik Mondal, Björn Rüter, Ute Burkard, Annika Osswald, and William Blum. 2022. “An Open-Label, Phase I/II Trial to Determine the Maximum Tolerated Dose and Investigate Safety, Pharmacokinetics and Efficacy of BI 836858, an Unconjugated Anti-CD33 Monoclonal Antibody, in Combination With Decitabine in Patients With Acute Myeloid Leukemia”. Haematologica 107 (12). Pavia, Italy, 2977-82. https://doi.org/10.3324/haematol.2022.281128.